Carisma Therapeutics, Inc. (CARM)
0.0396
0.00 (0.00%)
USD |
OTCM |
Feb 20, 16:00
Carisma Therapeutics Profit Margin (Quarterly) : 98.82% for Sept. 30, 2025
Profit Margin (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Profit Margin (Quarterly) Benchmarks
| ACADIA Pharmaceuticals, Inc. | 25.76% |
| Alnylam Pharmaceuticals, Inc. | 16.99% |
| Savara, Inc. | -- |
| BioMarin Pharmaceutical, Inc. | -3.91% |
| Imunon, Inc. | -- |
Profit Margin (Quarterly) Related Metrics
| Return on Assets | 40.20% |
| Operating Margin (Quarterly) | 96.83% |
| Return on Net Operating Assets | 144.4% |